Related Experiment Video
Updated: Mar 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic shock and access site choice
Samir B Pancholy1, Gaurav Patel, Sukrut P Nanavaty
1The Commonwealth Medical College, Scranton, PA, USA - pancholy8@gmail.com.
Transradial access (TRA) shows promise for patients with cardiogenic shock (CS) undergoing PCI, potentially offering better outcomes than transfemoral access (TFA). Further randomized trials are needed to confirm these findings due to existing biases.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Access
Background:
- Transradial access (TRA) utilization is increasing, but its use in patients with cardiogenic shock (CS) remains limited.
- Existing literature comparing TRA and transfemoral access (TFA) in CS patients is scarce, with some studies excluding this population.
- Operators have shown reluctance to adopt TRA for CS patients despite growing experience.
Purpose of the Study:
- To review and critically examine the existing literature on outcomes of percutaneous coronary intervention (PCI) in CS patients using TRA versus TFA.
- To compile and analyze data from various datasets, including non-published details, focusing on CS patients.
Main Methods:
- Systematic review and critical examination of published and non-published data from datasets comparing TRA and TFA in CS patients undergoing PCI.
- Detailed description and analysis of study populations, methodologies, and conclusions of included studies.
- Focus on access-site related outcomes in CS patients.
Main Results:
- Observational data suggests a composite outcome favoring TRA over TFA in CS patients undergoing PCI.
- A significant selection bias exists, with sicker CS patients often being triaged to TFA, complicating direct comparisons.
- Some high-quality adjusted analyses indicate better outcomes with TRA in this patient group.
Conclusions:
- While current observational data suggests potential benefits of TRA in CS patients undergoing PCI, interpretation is limited by selection bias.
- There is a clear and immediate need for a well-powered randomized trial to definitively evaluate the efficacy and safety of TRA versus TFA in CS patients.
- Further research is crucial to guide optimal vascular access strategies for patients with cardiogenic shock.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization II: Right Heart Catheterization
Cardiopulmonary Resuscitation III: AED Use
Introduction Cardiac Emergencies
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...

